(Total Views: 591)
Posted On: 10/09/2023 12:47:57 PM
Post# of 148878
WSJ today - Bristol Myers paying roughly $6 billion for Mirati - an oncology focused biotech. the article referenced that it's not yet approved, but had results in late-stage study. Further evidence that we are sitting on a very valuable asset - but until we get our internal house in order, it's "gold in the mine".
Come on CYDY - let's get a deal-maker in that CEO seat, and start moving us in that direction!
Come on CYDY - let's get a deal-maker in that CEO seat, and start moving us in that direction!
(10)
(0)
Scroll down for more posts ▼